ARCHIVES

FDA Plans Safety Reviews Of Newly Approved Drugs; Drug Safety Bills Introduced In Senate.

This article is from The Cancer Letter archive.

Vol. 33 No. 04 | February 2, 2007

Download PDF Visit The Full Archive

Related Articles

Clinton R&D Budget Amounts to a Cut, AAAS Study Says

April 18, 1997

NCA Members To Hear PDQ Issue, Reports On AIDs, Lung Cancer, Cell Invasiveness, Smoking Program, Small Business Grants

September 30, 1983

NCAB Accepts Report, Seeks Comment From Researchers, Patient Groups

May 19, 1995

In Brief: VP-16 NDA Approved By FDA Only For Refractory Testicular Cancer; Removed From Group C List

December 2, 1983

INSPIRE Enrollment Stopped; Thromboembolism Risk Cited

February 25, 2011

Maryland’s Greenebaum Cancer Center Wins NCI Designation.

September 12, 2008